According to PANews, VitaDAO, a decentralized autonomous organization (DAO) focused on funding longevity research projects, has introduced a new protocol named BIO. This initiative aims to unite global patients, scientists, and biotechnology developers to collectively support the development and commercialization of new therapies. The protocol leverages DAO to raise funds, utilizing proceeds from token sales to back relevant biotechnology projects, thereby facilitating the sharing of intellectual property. During its initial token generation event (TGE), BIO raised $6.2 million through a public sale, with participation from venture capital firms such as Zee Prime and 1kx. Details regarding the second round of TGE will be announced soon.